| |
| Issue |
Title |
| |
| Vol 22, No 2 (2025) |
THE FDA HAS APPROVED A NEW ANTIBIOTIC FOR THE TREATMENT OF UTIS |
Abstract
PDF (Rus)
|
|
article Editorial |
| |
| Vol 22, No 2 (2025) |
THE FDA HAS APPROVED THE FIRST DRUG FOR PEOPLE WITH PRADER – WILLI SYNDROME IN MEMORY OF A COLLEAGUE |
Abstract
PDF (Rus)
|
|
article Editorial |
| |
| Vol 22, No 2 (2025) |
THE FDA HAS APPROVED A NEW COMBINED MENINGOCOCCAL VACCINE |
Abstract
PDF (Rus)
|
|
article Editorial |
| |
| Vol 22, No 1 (2025) |
NEW DEVELOPMENT IN THE TREATMENT OF ATOPIC DERMATITIS |
Abstract
PDF (Rus)
|
|
article Editorial |
| |
| Vol 22, No 1 (2025) |
UPDATING THE REGIONAL CALENDAR OF IMMUNIZATIONS SCHEDULE IN MOSCOW |
Abstract
PDF (Rus)
|
|
article Editorial |
| |
| Vol 22, No 1 (2025) |
FDA APPROVES NEW HEMOPHILIA DRUG |
Abstract
PDF (Rus)
|
|
article Editorial |
| |
| Vol 21, No 6 (2024) |
The FDA has approved a new drug for the treatment of leukemia |
Abstract
PDF (Rus)
|
|
article editorial |
| |
| Vol 21, No 6 (2024) |
A new drug in the treatment of acute leukemia |
Abstract
PDF (Rus)
|
|
article editorial |
| |
| Vol 21, No 6 (2024) |
The EMA has approved dupilumab for the treatment of esophagitis in children from one year old |
Abstract
PDF (Rus)
|
|
article editorial |
| |
| Vol 21, No 5 (2024) |
THE JOURNAL OF PEDIATRIC PHARMACOLOGY IS INCLUDED IN SCOPUS |
Abstract
PDF (Rus)
|
|
Article Editorial |
| |
| Vol 21, No 5 (2024) |
THE FDA HAS APPROVED A DRUG AGAINST NIEMANN–PICK DISEASE, TYPE C |
Abstract
PDF (Rus)
|
|
Article Editorial |
| |
| Vol 21, No 5 (2024) |
THE FDA HAS APPROVED A NEW TREATMENT FOR HEMOPHILIA A OR B |
Abstract
PDF (Rus)
|
|
Article Editorial |
| |
| Vol 21, No 5 (2024) |
THE MONKEYPOX VACCINE IS APPROVED FOR ADOLESCENTS IN THE EU |
Abstract
PDF (Rus)
|
|
Article Editorial |
| |
| Vol 21, No 4 (2024) |
FDA APPROVED THE FIRST NASAL SPRAY WITH ADRENALINE TO ELIMINATE ANAPHYLAXIS |
Abstract
PDF (Rus)
|
|
article Editorial |
| |
| Vol 21, No 4 (2024) |
“CIRCLE OF GOOD” APPROVED A NEW DRUG FOR CHILDREN WITH DUCHENNE MUSCULAR DYSTROPHY |
Abstract
PDF (Rus)
|
|
article Editorial |
| |
| Vol 21, No 4 (2024) |
A NEW DRUG IN THE TREATMENT OF TUBERCULOSIS |
Abstract
PDF (Rus)
|
|
article Editorial |
| |
| Vol 21, No 4 (2024) |
FDA APPROVED A NEW DRUG FOR THE TREATMENT OF ATOPIC DERMATITIS |
Abstract
PDF (Rus)
|
|
article Editorial |
| |
| Vol 21, No 3 (2024) |
WHO HAS WARNED ABOUT GROWING BACTERIAL ANTIBIOTIC RESISTANCE |
Abstract
PDF (Rus)
|
|
article Editorial |
| |
| Vol 21, No 3 (2024) |
"CIRCLE OF GOOD" IS GOING TO BUY MEDICATION FOR MANAGEMENT OF CHILDREN WITH LARON'S SYNDROME |
Abstract
PDF (Rus)
|
|
article Editorial |
| |
| Vol 21, No 3 (2024) |
FDA HAS APPROVED THE LIQUID ADHD MEDICATION (NOT A STIMULANT) |
Abstract
PDF (Rus)
|
|
article Editorial |
| |
| Vol 21, No 3 (2024) |
FDA HAS APPROVED THE FIRST THERAPY FOR NEUROENDOCRINE TUMORS IN CHILDREN |
Abstract
PDF (Rus)
|
|
article Editorial |
| |
| Vol 21, No 3 (2024) |
FDA HAS APPROVED THE FIRST MEDICATION FOR RARE IMMUNITY-RELATED DISEASES |
Abstract
PDF (Rus)
|
|
article Editorial |
| |
| Vol 21, No 3 (2024) |
FDA HAS ASSIGNED RMAT STATUS TO RETT SYNDROME GENE THERAPY |
Abstract
PDF (Rus)
|
|
article Editorial |
| |
| Vol 21, No 3 (2024) |
EMA HAS APPROVED MEDICATION FOR BLOOD CLOTTING AT FACTOR VIII DEFICIENCY |
Abstract
PDF (Rus)
|
|
article Editorial |
| |
| Vol 21, No 2 (2024) |
FDA HAS APPROVED NEW DRUG TREATMENT FOR DUCHENE MUSCULAR DYSTROPHY |
Abstract
PDF (Rus)
|
|
article Editorial |
| |
| Vol 21, No 2 (2024) |
FDA HAS APPROVED NEW DRUG TREATMENT FOR HIV IN CHILDREN |
Abstract
PDF (Rus)
|
|
article Editorial |
| |
| Vol 21, No 2 (2024) |
THE FIRST CHILDREN’S REHABILITATION AND HIV IN THE COUNTRY HAS OPENED IN ST. PETERSBURG |
Abstract
PDF (Rus)
|
|
article Editorial |
| |
| Vol 21, No 2 (2024) |
EXPANDING THE LIST OF DISEASES OF THE FOUNDATION “CIRCLE OF KINDNESS” |
Abstract
PDF (Rus)
|
|
article Editorial |
| |
| Vol 21, No 2 (2024) |
EUROPEAN COMMISSION HAS APPROVED NEW VACCINE TO PROTECT CHILDREN FROM PNEUMOCOCCAL INFECTION |
Abstract
PDF (Rus)
|
|
article Editorial |
| |
| Vol 21, No 1 (2024) |
THE FDA HAS APPROVED TWO GENE THERAPY DRUGS FOR THE TREATMENT OF SICKLE CELL ANEMIA |
Abstract
PDF (Rus)
|
|
article Editorial |
| |
| Vol 21, No 1 (2024) |
THE FDA HAS APPROVED DUPILUMAB FOR THE PEDIATRIC TREATMENT OF ESOPHAGEAL DISEASES |
Abstract
PDF (Rus)
|
|
article Editorial |
| |
| Vol 21, No 1 (2024) |
FOR THE FIRST TIME, THE FDA HAS APPROVED A GEL FOR THE TREATMENT OF MOLLUSCUM CONTAGIOSUM AT HOME |
Abstract
PDF (Rus)
|
|
article Editorial |
| |
| Vol 21, No 1 (2024) |
THE MINISTRY OF HEALTH HAS MADE CHANGES TO THE NATIONAL CALENDAR OF PREVENTIVE VACCINATIONS |
Abstract
PDF (Rus)
|
|
article Editorial |
| |
| Vol 20, No 6 (2023) |
THE FDA HAS APPROVED THE THE FIRST DRUG FOR THE CONGENITAL FORM OF THROMBOTIC THROMBOCYTOPENIC PURPURA |
Abstract
PDF (Rus)
|
|
article Editorial |
| |
| Vol 20, No 6 (2023) |
THE FDA HAS APPROVED THE FIRST VACCINE AGAINST THE CHIKUNGUNYA VIRUS |
Abstract
PDF (Rus)
|
|
article Editorial |
| |
| Vol 20, No 6 (2023) |
THE RESEARCH OF THE VACCINE AGAINST HUMAN PAPILLOMA VIRUS AMONG CHILDREN |
Abstract
PDF (Rus)
|
|
article Editorial |
| |
| Vol 20, No 6 (2023) |
THE NEW VACCINE AGAINST MENINGOCOCCOSIS |
Abstract
PDF (Rus)
|
|
article Editorial |
| |
| Vol 20, No 6 (2023) |
SINCE THE BEGINNING OF THE YEAR, 960 THOUSAND NEWBORNS HAVE UNDERGONE EXTENDED SCREENING |
Abstract
PDF (Rus)
|
|
article Editorial |
| |
| Vol 20, No 6 (2023) |
THE FDA HAS APPROVED THE TRIPLE COMBINATION TOPICAL ACNE REMEDY |
Abstract
PDF (Rus)
|
|
article Editorial |
| |
| 1 - 39 of 39 Items |
|
